Published in Acta Biochim Biophys Hung on January 01, 1987
Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med (1991) 16.01
The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic Biol Med (1992) 3.52
Prevalence, control and awareness of high blood pressure among Canadian adults. Canadian Heart Health Surveys Research Group. CMAJ (1992) 2.98
Distribution of blood pressure and hypertension in Canada and the United States. Am J Hypertens (2001) 2.96
Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic Res Commun (1989) 2.81
Tobacco use, occupation, coffee, various nutrients, and bladder cancer. J Natl Cancer Inst (1980) 2.44
Cytotoxicity and genotoxicity of lipid-oxidation products. Am J Clin Nutr (1993) 2.06
Rationale for and outline of the recommendations of the Working Group on Hypercholesterolemia and Other Dyslipidemias: interim report. Dyslipidemia Working Group of Health Canada. Can J Cardiol (1998) 1.88
Biochemical, structural, and functional properties of oxidized low-density lipoprotein. Chem Res Toxicol (1991) 1.82
Drinking water hardness and urolithiasis. Ann Intern Med (1978) 1.45
Canadian Cardiovascular Society Consensus Conference 2002: Management of heart disease in the elderly patient. Can J Cardiol (2004) 1.44
The 2000 Canadian recommendations for the management of hypertension: Part one--therapy. Can J Cardiol (2001) 1.42
Role of vitamin E in preventing the oxidation of low-density lipoprotein. Am J Clin Nutr (1991) 1.41
Artificial sweeteners and human bladder cancer. Lancet (1977) 1.40
Evaluation of alternative calculation methods for determining LDL cholesterol. Vnitr Lek (2008) 1.38
Possible mutagens derived from lipids and lipid precursors. Mutat Res (1990) 1.38
Estimation of peroxidative damage. A critical review. Pathol Biol (Paris) (1996) 1.34
Methods for determination of aldehydic lipid peroxidation products. Free Radic Biol Med (1989) 1.25
Prepupal larval mosaics in Drosophila melanogaster. Nature (1976) 1.25
Multiple cardiovascular disease risk factors in Canadian adults. Canadian Heart Health Surveys Research Group. CMAJ (1992) 1.15
Ketone aldehydes in animal tissues. Proc Natl Acad Sci U S A (1967) 1.14
A minimal prevalence study of diagnosed diabetes in Newfoundland and Labrador. Can J Public Health (1991) 1.13
Common variable immunodeficiency, Hodgkin's disease, and other malignancies in a Newfoundland family. Lancet (1975) 1.12
Chemistry and pathophysiology of oxidation of LDL. Rev Physiol Biochem Pharmacol (1996) 1.11
[Epidemiological profile of thyroid volume and disorders in Slovakia]. Vnitr Lek (2000) 1.10
Lipid peroxidation and its role in atherosclerosis. Br Med Bull (1993) 1.08
Increased thyroid volume and prevalence of thyroid disorders in an area heavily polluted by polychlorinated biphenyls. Eur J Endocrinol (1998) 1.08
The role of vitamin E and carotenoids in preventing oxidation of low density lipoproteins. Ann N Y Acad Sci (1989) 1.07
Effect of antioxidants on oxidative modification of LDL. Ann Med (1991) 1.05
Endogenous antioxidants and lipoprotein oxidation. Biochem Soc Trans (1990) 0.93
Technique for determining the bactericidal effect of drug combinations. Antimicrob Agents Chemother (1974) 0.93
Adherence to management of high blood pressure: recommendations of the Canadian Coalition for High Blood Pressure Prevention and Control. Can J Public Health (1999) 0.90
Venous thromboembolism in association with features of the metabolic syndrome. QJM (2007) 0.86
Urolithiasis--a study of drinking water hardness and genetic factors. J Chronic Dis (1980) 0.84
Relationships among oxidation of low-density lipoprotein, antioxidant protection, and atherosclerosis. Adv Pharmacol (1997) 0.81
The search for new cancerostatic agents. Ciba Found Symp (1978) 0.79
Static and dynamic pupillometry for determination of the course of gradual detoxification of opiate-addicted patients. Eur Arch Psychiatry Clin Neurosci (1990) 0.79
Inhibition of LDL oxidation by antioxidants. EXS (1992) 0.78
Isolation of methylglyoxal from liver. Proc Natl Acad Sci U S A (1978) 0.78
A new class of synthetic biological response modifiers: the methylfurylbutyrolactones (Nafocare B). J Biol Response Mod (1986) 0.77
Comparative trial of doxazosin and atenolol on cardiovascular risk reduction in systemic hypertension. The Alpha Beta Canada Trial Group. Am J Cardiol (1993) 0.77
Thyroid volume, iodine intake, autoimmune thyroid disorders, inborn factors, and endocrine disruptors: twenty-year studies of multiple effects puzzle in Slovakia. Endocr Regul (2012) 0.76
Modification of human low density lipoprotein by lipid peroxidation. Basic Life Sci (1988) 0.75
[Ultrasonography of the neonatal hip: state of the art and perspectives]. Radiol Med (1996) 0.75
Geology and disease in Newfoundland. Can Med Assoc J (1973) 0.75
Comorbidity of obsessive compulsive disorder in patients with eating disorders. Eat Weight Disord (1998) 0.75
[Radiotherapy in small animal medicine: fundamentals, indications and significance]. Schweiz Arch Tierheilkd (1994) 0.75
[General anesthesia in children with labio-maxillo-palatine clefts]. Stomatologia (Bucur) (1970) 0.75
[Optical rotation and conformation. VI. N.M.R. spectra and conformation of some stereoisomeric 2.3-disubstituted morpholines and 5-oxomorpholines]. Chem Ber (1972) 0.75
Prevention of fatal and nonfatal ischemic heart disease by early treatment of hypertension. Cardiology (1985) 0.75
Tropane alkaloids. Nat Prod Rep (1984) 0.75
On the hepato-protective effect of selenium in carbon tetrachloride poisoning in albino rats. Experientia (1965) 0.75
[Prevention and treatment of early and rare complications after strumectomy]. Bratisl Lek Listy (1997) 0.75
[Prevalence of HIV antibodies in intravenous drug-dependent patients 1986 and 1987 in Vienna]. Wien Klin Wochenschr (1987) 0.75
[Diagnosis of diabetic macroangiopathy of the lower extremities using rheography]. Vnitr Lek (1990) 0.75
[The use of epsilon-amino-caproic acid (EACA) for hemostasis in selective dental extractions in hemophiliacs]. Stomatologia (Bucur) (1971) 0.75
Multi-channel commutator for recording biopotentials from small animals. Physiol Behav (1978) 0.75
[Echographic anatomy of the newborn hip and high-resolution equipment: internal capsular stria and perichondrial gap]. Radiol Med (1990) 0.75
Novel method of configurational correlation: (+)-sedridine and S-(+)-octan-2-ol. Chem Ind (1968) 0.75
[The beginning stages of Cushing's syndrome]. Vnitr Lek (1984) 0.75
[Intraventricular conduction disorders in hypertension]. Orv Hetil (1978) 0.75
[Microcirculation in the subcutaneous layer and in muscles in diabetes mellitus]. Vnitr Lek (1990) 0.75
[Fractionated opiate withdrawal with tiapride and naloxone, a new treatment approach]. Psychiatr Prax (1989) 0.75
[Echography in hip dysplasia in neonates and infants. Echographic anatomy, technic and case material]. Radiol Med (1987) 0.75
Vitamin E and atherosclerosis: an overview. J Nutr Sci Vitaminol (Tokyo) (1992) 0.75
["Induced detoxification treatment" of opiate dependent patients--a new therapy concept]. Wien Klin Wochenschr (1989) 0.75
Tropane alkaloids. Nat Prod Rep (1985) 0.75
[Reduction of bleeding by vasoconstrictive drugs infiltration in the surgery cleft lip and cleft palate]. Stomatologia (Bucur) (1972) 0.75
[Determination of the potential doubling time of tumors using bromodeoxyuridine and flow cytometry]. Schweiz Arch Tierheilkd (1997) 0.75
Tropane alkaloids. Nat Prod Rep (1986) 0.75
[Echography of the hip of the newborn infant]. Radiol Med (1990) 0.75
[General anesthesia in temporomandibular ankylosis]. Stomatologia (Bucur) (1970) 0.75
On the protective action (anticirrhogenic) of inorganic selenium in hepatic lesions of alimentary origin. Rom Med Rev (1967) 0.75